1 | MRD58, SET
|
| De novo mutations in the SET nuclear proto-oncogene, encoding a component of the inhibitor of histone acetyltransferases (INHAT) complex in patients with nonsyndromic intellectual disability.
|
| Stevens SJC, van der Schoot V, Leduc MS, Rinne T, Lalani SR, Weiss MM, van Hagen JM, Lachmeijer AMA; CAUSES Study, Stockler-Ipsiroglu SG, Lehman A, Brunner HG.
|
| Hum Mutat 39(7):1014-1023. doi: 10.1002/humu.23541. Epub 2018 May 10.
2018
|
2 | PRKD2, SET
|
| Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A.
|
| Irie A, Harada K, Araki N, Nishimura Y.
|
| PLoS One 7(12):e51242. doi: 10.1371/journal.pone.0051242. Epub 2012 Dec 14.
2012
|
3 | SET
|
| SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.
|
| Christensen DJ, Chen Y, Oddo J, Matta KM, Neil J, Davis ED, Volkheimer AD, Lanasa MC, Friedman DR, Goodman BK, Gockerman JP, Diehl LF, de Castro CM, Moore JO, Vitek MP, Weinberg JB.
|
| Blood 118(15):4150-8. Epub 2011 Aug 15.
2011
|
4 | SET
|
| The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.
|
| Trotta R, Ciarlariello D, Dal Col J, Mao H, Chen L, Briercheck E, Yu J, Zhang J, Perrotti D, Caligiuri MA.
|
| Blood 117(8):2378-84. Epub 2010 Dec 14.
2011
|
5 | MCPH1, SET
|
| SET nuclear oncogene associates with microcephalin/MCPH1 and regulates chromosome condensation.
|
| Leung JW, Leitch A, Wood JL, Shaw-Smith C, Metcalfe K, Bicknell LS, Jackson AP, Chen J.
|
| J Biol Chem 286(24):21393-400. Epub 2011 Apr 22.
2011
|
6 | SET
|
| Negative regulation of neuronal cell differentiation by INHAT subunit SET/TAF-Iβ.
|
| Kim DW, Kim KB, Kim JY, Lee KS, Seo SB.
|
| Biochem Biophys Res Commun 400(3):419-25. Epub 2010 Aug 26.
2010
|
7 | SET
|
| Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction.
|
| Karetsou Z, Emmanouilidou A, Sanidas I, Liokatis S, Nikolakaki E, Politou AS, Papamarcaki T.
|
| BMC Biochem 10:10.
2009
|
8 | SET
|
| SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
|
| Quentmeier H, Schneider B, Röhrs S, Romani J, Zaborski M, Macleod RA, Drexler HG.
|
| J Hematol Oncol 2:3.
2009
|
9 | NUP214, SET
|
| The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
|
| Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP.
|
| Blood 111(9):4668-80. Epub 2008 Feb 25.
2008
|
10 | DEK,PARP1,SET
|
| SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery.
|
| Gamble MJ, Fisher RP.
|
| Nat Struct Mol Biol 14(6):548-55. Epub 2007 May 27. 2007
|
11 | MORF4L1, SET, FIGF, CCT3
|
| Gene expression in pharyngeal arch 1 during human embryonic development.
|
| Cai J, Ash D, Kotch LE, Jabs EW, Attie-Bitach T, Auge J, Mattei G, Etchevers H, Vekemans M, Korshunova Y, Tidwell R, Messina DN, Winston JB, Lovett M.
|
| Hum Mol Genet 14(7):903-12. Epub 2005 Feb 9. 2005
|
12 | PCOTH, SET
|
| PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET.
|
| Anazawa Y, Nakagawa H, Furihara M, Ashida S, Tamura K, Yoshioka H, Shuin T, Fujioka T, Katagiri T, Nakamura Y.
|
| Cancer Res 65(11):4578-86. 2005
|
13 | CREBBP, SET
|
| The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein.
|
| Karetsou Z, Martic G, Sflomos G, Papamarcaki T.
|
| Biochem Biophys Res Commun 335(2):322-7. 2005
|
14 | CDK5, SET
|
| The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.
|
| Qu D, Li Q, Lim HY, Cheung NS, Li R, Wang JH, Qi RZ.
|
| J Biol Chem 277(9):7324-32. 2002
|
15 | SET
|
| HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.
|
| Fan Z, Beresford PJ, Zhang D, Lieberman J.
|
| Mol Cell Biol 22(8):2810-20. 2002
|
16 | SET
|
| The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A.
|
| Li M, Makkinje A, Damuni Z.
|
| J Biol Chem 271(19):11059-62. 1996
|
17 | WVR, SET, WGN1, VCAN
|
| Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14.
|
| Brown DM, et al.
|
| Arch Ophthalmol 113 : 671-675. 1995
|
18 | SET
|
| Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.
|
| Nagata K, et al.
|
| Proc Natl Acad Sci U S A 92 : 4279-4283. 1995
|
19 | NUP214, SET
|
| can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes : characterization of the set gene.
|
| von Lindern M, et al.
|
| Mol Cell Biol 12 : 3346-3355. 1992
|